Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCytokinetics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 11 | -$1.84 | -$1.48 | -$1.65 |
| Q2 2026 | 11 | -$1.73 | -$1.53 | -$1.63 |
| Q3 2026 | 12 | -$1.57 | -$1.32 | -$1.45 |
| Q4 2026 | 11 | -$1.53 | -$1.32 | -$1.44 |
| Q1 2027 | 4 | -$2.36 | -$0.79 | -$1.38 |
| Q2 2027 | 4 | -$2.29 | -$0.77 | -$1.34 |
| Q3 2027 | 7 | -$2.10 | -$0.71 | -$1.23 |
| Q4 2027 | 4 | -$1.34 | -$0.45 | -$0.78 |
| Q1 2028 | 5 | -$2.33 | -$0.78 | -$1.36 |
| Q2 2028 | 6 | -$1.92 | -$0.64 | -$1.12 |
| Q3 2028 | 9 | -$4.36 | -$1.46 | -$2.55 |
| Q4 2028 | 5 | -$1.12 | -$0.37 | -$0.65 |
Cytokinetics Inc Earnings Date And Information
Cytokinetics Inc last posted its earnings results on Thursday, August 6th, 2026. The company reported $-1.5 earnings per share for the quarter, topping analysts' consensus estimates of $-1.63 by $0.13. The company had revenue of 31.91 M for the quarter and had revenue of 88.04 M for the year. Cytokinetics Inc has generated $-7 earnings per share over the last year ($-6.54 diluted earnings per share) and currently has a price-to-earnings ratio of -10.66. Cytokinetics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Cytokinetics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | -$1.63 | -$1.50 | 0.13 | $17.59 M | $31.91 M |
| 05/05/2026 | Q1 2026 | -$1.67 | -$1.67 | 0 | $8.52 M | $19.36 M |
| 02/26/2026 | Q4 2025 | N/A | -$1.49 | N/A | $6.93 M | $17.76 M |
| 11/05/2025 | Q3 2025 | -$1.59 | -$2.55 | -0.96 | $6.05 M | $1.94 M |
| 08/07/2025 | Q2 2025 | -$1.34 | -$1.12 | 0.22 | $2.11 M | $66.77 M |
| 05/06/2025 | Q1 2025 | -$1.41 | -$1.36 | 0.05 | $3.42 M | $1.58 M |
| 02/27/2025 | Q4 2024 | -$1.29 | -$1.27 | 0.02 | $1.75 M | $16.93 M |
| 11/07/2024 | Q3 2024 | N/A | -$1.36 | N/A | $1.21 M | $463.00 K |
| 08/09/2024 | Q2 2024 | N/A | -$1.31 | N/A | $7.61 M | $249.00 K |
| 05/10/2024 | Q1 2024 | N/A | -$1.33 | N/A | $912.85 K | $835.00 K |
| 02/28/2024 | Q4 2023 | N/A | -$1.38 | N/A | $7.62 M | $1.67 M |
| 11/03/2023 | Q3 2023 | N/A | -$1.35 | N/A | $20.24 M | $378.00 K |
| 08/03/2023 | Q2 2023 | -$1.23 | -$1.34 | -0.11 | $5.67 M | $867.00 K |
| 05/05/2023 | Q1 2023 | N/A | -$1.36 | N/A | $2.08 M | $4.61 M |
| 03/01/2023 | Q4 2022 | -$1.22 | -$1.39 | -0.17 | $7.10 M | $1.96 M |
| 11/04/2022 | Q3 2022 | N/A | -$1.88 | N/A | $3.51 M | $2.52 M |
| 08/05/2022 | Q2 2022 | N/A | -$0.34 | N/A | $3.73 M | $88.97 M |
| 05/06/2022 | Q1 2022 | N/A | -$1.19 | N/A | $4.35 M | $1.15 M |
| 02/25/2022 | Q4 2021 | N/A | -$0.36 | N/A | $5.80 M | $55.60 M |
| 11/05/2021 | Q3 2021 | N/A | -$0.95 | N/A | $5.98 M | $5.44 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cytokinetics Inc Earnings: FAQ's
In the previous quarter, Cytokinetics Inc (:CYTK) reported $-1.5 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.63 by $0.13.
The conference call for Cytokinetics Inc's latest earnings report can be listened to online.
The conference call transcript for Cytokinetics Inc's latest earnings report can be read online.
Cytokinetics Inc (:CYTK) has a recorded annual revenue of $88.04 M.
Cytokinetics Inc (:CYTK) has a recorded net income of $-784,955,000.Cytokinetics Inc has generated $-6.54 earnings per share over the last four quarters.
Cytokinetics Inc (:CYTK) has a price-to-earnings ratio of -10.66 and price/earnings-to-growth ratio is 0.32.